Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Dorsomorphin: Precision AMPK and BMP Pathway Inhibitor fo...

    2026-02-05

    Dorsomorphin (Compound C): A Precision Tool for Dissecting AMPK and BMP Signaling in Translational Research

    Principle Overview: Dual-Pathway Inhibition and Mechanistic Insights

    Dorsomorphin (Compound C), available from APExBIO, is a cornerstone small molecule for probing and modulating the AMP-activated protein kinase (AMPK) and bone morphogenetic protein (BMP)/Smad signaling axes. As an ATP-competitive AMPK inhibitor (Ki = 109 nM), Dorsomorphin exhibits high selectivity over kinases such as PKA, PKC, and JAK3. Its dual function as a BMP signaling inhibitor—blocking Smad 1/5/8 phosphorylation—unlocks a unique experimental landscape for investigating metabolic regulation, autophagy, neural stem cell differentiation, and iron metabolism modulation.

    Mechanistically, Dorsomorphin potently suppresses downstream phosphorylation events, including an 80% reduction in acetyl-CoA carboxylase (ACC) phosphorylation, and inhibits autophagic proteolysis. The compound induces dorsalization in zebrafish embryos and has demonstrated efficacy in reducing hepatic hepcidin mRNA levels, thereby impacting systemic iron homeostasis. Its defined solubility profile—insoluble in water and ethanol, but highly soluble in DMSO (≥8.49 mg/mL with warming/sonication)—supports robust application across cell-based and in vivo models.

    Optimized Experimental Workflow: Step-by-Step Protocol Enhancements

    1. Compound Preparation

    • Stock Solution: Dissolve Dorsomorphin in DMSO to a concentration of ≥8.49 mg/mL. Gentle warming (37°C) and ultrasonic treatment are recommended to ensure complete dissolution. Avoid water or ethanol as solvents due to insolubility.
    • Aliquoting & Storage: Prepare aliquots for single-use to minimize freeze-thaw cycles. Store solid compound at -20°C; DMSO solutions should be used promptly and not stored long-term.

    2. Cell Culture Applications

    • AMPK Inhibition in Hepatocytes/HeLa Cells: Use at 4–40 μM final concentration. Pre-treat cells with Dorsomorphin for 1–2 hours prior to stimulation (e.g., metabolic stress, LPS).
    • BMP4-Induced SMAD Phosphorylation Inhibition: For BMP pathway studies, pre-incubate cells with Dorsomorphin at 0.5–5 μM range; IC50 for SMAD1/5/8 phosphorylation is 0.47 μM.
    • Neural Stem Cell Differentiation: Apply in the 2–10 μM range to promote self-renewal and neural induction by inhibiting BMP signaling.
    • Autophagy Regulation: To study autophagic flux, combine Dorsomorphin with autophagy inducers (e.g., starvation, rapamycin) and monitor LC3-II conversion, p62 turnover, and autophagosome formation via immunoblotting or fluorescence microscopy.

    3. In Vivo Use

    • Animal Models: For modulation of iron metabolism or inflammatory signaling, administer Dorsomorphin intraperitoneally at 10 mg/kg. Monitor downstream effects such as serum iron levels, hepcidin expression, and inflammatory cytokine profiles.
    • Zebrafish Embryo Dorsalization: Expose embryos to 10–40 μM Dorsomorphin to induce dorsalized phenotypes, leveraging its BMP inhibitory activity for developmental biology studies.

    Advanced Applications and Comparative Advantages

    Dissecting AMPK Signaling in Disease Models

    Recent studies, including the 2024 investigation by Lei et al., highlight the pivotal role of AMPK in regulating M1 macrophage polarization through the JAK2/STAT3 pathway, attenuating airway inflammation in obesity-related asthma. By selectively inhibiting the AMPK signaling pathway with Dorsomorphin, researchers can recapitulate the metabolic and inflammatory imbalances seen in chronic disease, enabling precise dissection of downstream events such as NF-κB activation, cytokine secretion, and insulin resistance.

    For cancer research and metabolic disease models, Dorsomorphin’s robust inhibition of ACC phosphorylation and autophagy regulation empowers investigation into tumor cell metabolism, chemoresistance, and cell survival pathways. Its dual action also enables experiments that require simultaneous modulation of cellular energy homeostasis and differentiation cues.

    Neural Induction and Stem Cell Fate Decisions

    Dorsomorphin is widely used in protocols for neural stem cell differentiation and maintenance of pluripotency. By inhibiting BMP/Smad signaling, it efficiently promotes neural induction in human embryonic stem cells, offering a chemically defined alternative to recombinant protein-based approaches. This application is particularly advantageous for generating homogeneous neural progenitor populations for disease modeling and regenerative medicine.

    Iron Metabolism and BMP/Smad Pathway Interrogation

    Through suppression of hepatic hepcidin transcription, Dorsomorphin modulates systemic iron levels—an asset for studies of anemia, hemochromatosis, and inflammation-induced iron dysregulation.

    Comparative Literature Landscape

    Troubleshooting and Optimization Tips

    • Solubility: If incomplete dissolution occurs, extend sonication or increase temperature incrementally (up to 40°C). Avoid prolonged exposure to high temperatures to preserve compound integrity.
    • Cytotoxicity: Monitor cell viability, especially at higher concentrations (>20 μM). Titrate dose for each cell line; toxicity may vary with metabolic rate and passage number.
    • Off-Target Effects: While Dorsomorphin is highly selective, prolonged exposure or high doses may impact kinases outside AMPK/BMP families. Include vehicle and negative controls to distinguish specific from off-target effects.
    • Batch Consistency: Use APExBIO’s validated lots for reproducibility. Document lot numbers and preparation conditions in lab records.
    • Storage: Prepare fresh DMSO solutions as needed. Solid Dorsomorphin is stable at -20°C; avoid repeated freeze-thaw cycles.
    • Readout Optimization: For autophagy studies, pair Dorsomorphin treatment with dynamic markers (e.g., LC3, p62) and functional assays (e.g., flux analysis with bafilomycin A1) for increased interpretability.
    • In Vivo Dosing: For animal studies, ensure accurate weight-based dosing and monitor for signs of systemic toxicity or off-target effects, especially in chronic regimens.

    Future Outlook: Expanding the Dorsomorphin Toolkit

    Dorsomorphin (Compound C) continues to drive innovation at the intersection of metabolic, inflammatory, and differentiation research. As highlighted by Lei et al. (2024), targeting the AMPK pathway offers new therapeutic avenues for diseases such as obesity-related asthma, where inflammatory and metabolic signals converge. The compound’s dual AMPK/BMP inhibition profile makes it uniquely suited for integrative disease modeling, regenerative medicine, and precision oncology.

    Emerging directions include combinatorial studies with other pathway modulators, CRISPR-based genetic models to validate specificity, and advanced readouts such as single-cell transcriptomics to unravel context-specific effects. The expanding literature underscores Dorsomorphin’s role not just as a tool compound, but as a strategic enabler of translational breakthroughs.

    For researchers seeking reliable, high-purity Dorsomorphin for their experiments, APExBIO remains the trusted supplier, supporting cutting-edge workflows from bench to publication.